Table 2

Combination of GC-marker immunoreactivity in the series of FL

Triple-positive

N.cases (%)

Double-positive

N.cases (%)

Single-positive

N.cases (%)


Groups (N.cases)

HGAL/BCL6/CD10

HGAL/BCL6

HGAL/CD10

BCL6

HGAL


In situ FL (6)

3 (50%)

-

3 (50%)

-

-


Nodal FL (61)

53 (87.1%)

4 (6.5%)

2 (3.2%)

2 (3.2%)

-


FL+LBCL (10)

8 (80%)

1 (10%)

-

-

1 (10%)


CFL (5)

5 (100%)

-

-

-

-


Total (82)

69 (84.2%)

5 (6.1%)

5 (6.1%)

2 (2.4%)

1 (1.2%)


Goteri et al. Diagnostic Pathology 2011 6:97   doi:10.1186/1746-1596-6-97

Open Data